Advanced Biomed (ADVB) EBT (2023 - 2026)

Advanced Biomed has disclosed EBT across 4 years of filings, most recently posting -$488942.0 for Q1 2026.

• EBT for Q1 2026 came in at -$488942.0, up 59.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 262.33% YoY), and the FY2025 annual result was -$3.3 million, down 17.13% from the prior year.
• EBT came in at -$488942.0 for Q1 2026 at Advanced Biomed, down from $7.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $7.0 million in Q4 2025 to a low of -$1.5 million in Q2 2025.
• The 4-year median for EBT is -$534218.0 (2024), against an average of $57593.7.
• Across the five-year window, EBT plunged 298.7% in 2024 and jumped 1308.33% in 2025, its largest moves.
• Advanced Biomed's EBT stood at -$145345.0 in 2023, then tumbled by 298.7% to -$579494.0 in 2024, then surged by 1308.33% to $7.0 million in 2025, then tumbled by 106.98% to -$488942.0 in 2026.
• The last three EBT figures came in at -$488942.0 (Q1 2026), $7.0 million (Q4 2025), and -$386901.0 (Q3 2025), per Business Quant data.